Support for LAist comes from
We Explain L.A.
Stay Connected

Share This

This is an archival story that predates current editorial management.

This archival content was written, edited, and published prior to LAist's acquisition by its current owner, Southern California Public Radio ("SCPR"). Content, such as language choice and subject matter, in archival articles therefore may not align with SCPR's current editorial standards. To learn more about those standards and why we make this distinction, please click here.


Court Examines Politics over Science in Medical Marijuana Laws

Photo by Neeta Lind via Flickr
We need to hear from you.
Today during our spring member drive, put a dollar value on the trustworthy reporting you rely on all year long. The local news you read here every day is crafted for you, but right now, we need your help to keep it going. In these uncertain times, your support is even more important. We can't hold those in power accountable and uplift voices from the community without your partnership. Thank you.

A group has sued the federal government for disseminating inaccurate information about medical marijuana. The LA Times points out that although the Obama administration has stated "that science should be guiding government judgments in controversial matters of medicine and technology, not the prevailing political mood," a federal lawyer told the U.S. 9th Circuit Court of Appeals yesterday that marijuana "has no currently accepted medical use." By law, the government is not allowed to publish false information. In March, General Attorney Eric Holder did stop federal agents from raiding California dispensaries as long as they were following state law.

"The science to support medical marijuana is overwhelming. It's time for the federal government to acknowledge the efficacy of medical marijuana and stop holding science hostage to politics," said Steph Sherer, director of Americans for Safe Access. The government lawyer said they have "countless pieces of information" in its massive archives about the drug.

Most Read